Question 1

Does RhumbLine Advisers own AXSM stock?

Accepted Answer

Yes. As of its Q2 2026 13F, RhumbLine Advisers holds 44,815 shares of AXSM (Axsome Therapeutics), worth $11M.

Question 2

How many shares of AXSM does RhumbLine Advisers own?

Accepted Answer

As of its Q2 2026 13F, RhumbLine Advisers holds 44,815 shares of AXSM (Axsome Therapeutics).

Question 3

What is RhumbLine Advisers' AXSM position worth?

Accepted Answer

As of its Q2 2026 13F, RhumbLine Advisers' AXSM position is worth $11M.

Question 4

Is RhumbLine Advisers buying or selling AXSM?

Accepted Answer

In Q2 2026, RhumbLine Advisers reduced its AXSM position by 6,804 shares (-13.2%).

Question 5

When did RhumbLine Advisers first buy AXSM?

Accepted Answer

RhumbLine Advisers first reported AXSM in its Q2 2019 13F and has listed it in 29 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	44,815	-13.2%	$11M	0.0%	$244.77	0
2026-Q1	Decreased	51,619	-1.2%	$8.7M	0.0%	$169.02	0
2025-Q4	Decreased	52,233	-14.1%	$9.5M	0.0%	$182.64	0
2025-Q3	Decreased	60,778	-1.7%	$7.4M	0.0%	$121.45	0
2025-Q2	Increased	61,807	+12.9%	$6.5M	0.0%	$104.39	31
2025-Q1	Increased	54,760	+6.9%	$6.4M	0.0%	$116.63	29
2024-Q4	Decreased	51,245	-0.3%	$4.3M	0.0%	$84.61	0
2024-Q3	Decreased	51,393	-6.4%	$4.6M	0.0%	$89.87	0